In the latest session, Doximity Inc (NYSE: DOCS) closed at $28.66 up 2.39% from its previous closing price of $27.99. In other words, the price has increased by $+0.67 from its previous closing price. On the day, 995073 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of Doximity Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 32.19. For the most recent quarter (mrq), Quick Ratio is recorded 7.97 and its Current Ratio is at 7.97. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on February 26, 2024, initiated with a Market Perform rating and assigned the stock a target price of $32.
On January 03, 2024, Barclays started tracking the stock assigning a Equal Weight rating and target price of $31.
BofA Securities Upgraded its Underperform to Neutral on January 02, 2024, whereas the target price for the stock was revised from $21 to $29.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 16 when Overpeck Craig sold 1,500 shares for $30.02 per share. The transaction valued at 45,030 led to the insider holds 112,971 shares of the business.
Wampler Kira Scherer sold 2,500 shares of DOCS for $67,625 on Feb 01. The Director now owns 10,258 shares after completing the transaction at $27.05 per share. On Jan 02, another insider, Wampler Kira Scherer, who serves as the Director of the company, sold 5,000 shares for $28.27 each. As a result, the insider received 141,330 and left with 10,258 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DOCS now has a Market Capitalization of 5.35B and an Enterprise Value of 4.65B. As of this moment, Doximity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 43.19, and their Forward P/E ratio for the next fiscal year is 30.38. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.09. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.42 while its Price-to-Book (P/B) ratio in mrq is 6.17. Its current Enterprise Value per Revenue stands at 9.93 whereas that against EBITDA is 26.85.
Stock Price History:
Over the past 52 weeks, DOCS has reached a high of $37.10, while it has fallen to a 52-week low of $19.71. The 50-Day Moving Average of the stock is 28.51, while the 200-Day Moving Average is calculated to be 27.36.
Shares Statistics:
For the past three months, DOCS has traded an average of 1.89M shares per day and 1.95M over the past ten days. A total of 120.68M shares are outstanding, with a floating share count of 117.28M. Insiders hold about 37.14% of the company’s shares, while institutions hold 49.76% stake in the company. Shares short for DOCS as of Jan 31, 2024 were 8.91M with a Short Ratio of 4.72, compared to 8.5M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 4.78% and a Short% of Float of 8.82%.
Earnings Estimates
There are 13 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.2 for the current quarter, with a high estimate of $0.22 and a low estimate of $0.14, while EPS last year was $0.2. The consensus estimate for the next quarter is $0.21, with high estimates of $0.25 and low estimates of $0.18.
Analysts are recommending an EPS of between $0.92 and $0.87 for the fiscal current year, implying an average EPS of $0.9. EPS for the following year is $0.95, with 13 analysts recommending between $1.03 and $0.87.
Revenue Estimates
A total of 13 analysts believe the company’s revenue will be $116.52M this quarter.It ranges from a high estimate of $116.76M to a low estimate of $116.3M. As of the current estimate, Doximity Inc’s year-ago sales were $110.97M, an estimated increase of 5.00% from the year-ago figure.
A total of 16 analysts have provided revenue estimates for DOCS’s current fiscal year. The highest revenue estimate was $474.12M, while the lowest revenue estimate was $473M, resulting in an average revenue estimate of $473.83M. In the same quarter a year ago, actual revenue was $419.05M, up 13.10% from the average estimate. Based on 16 analysts’ estimates, the company’s revenue will be $520.68M in the next fiscal year. The high estimate is $526.06M and the low estimate is $514.37M. The average revenue growth estimate for next year is up 9.90% from the average revenue estimate for this year.
